What is the 13F Pro Quality Score for EYE?

13F Pro ranks National Vision Holdings, Inc. (EYE) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View EYE's current score at https://13fpro.ai/research/EYE (free sign-up required for the full ranking).

Where does 13F Pro source EYE data?

All National Vision Holdings, Inc. fundamentals and ownership data come directly from SEC EDGAR. National Vision Holdings, Inc. files with the SEC under CIK 1710155. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is EYE in?

National Vision Holdings, Inc. (EYE) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is EYE research updated on 13F Pro?

EYE's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

National Vision Holdings, Inc.(EYE)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1710155 EYE stock profile & AI dashboard →

13F Pro Quality Score

55.4/100

Rank #1,160 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

53.3/100

Profitability

62.5/100

Balance Sheet

57.4/100

Earnings Quality

30.0/100

Free Cash Flow

54.6/100

Institutional Flow

39.0/100

Revenue Scale

62.7/100

Dilution Risk

52.7/100

EYE Stock Analysis & AI Quality Score

AI stock analysis and institutional research for National Vision Holdings, Inc. (EYE), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EYE at 55.4/100 on a 32-signal composite quality model, placing it at rank #1,160 of 2,879 stocks — the top half of the AI-ranked universe. Areas of concern include earnings quality (30.0) and institutional flow (39.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), National Vision Holdings, Inc. reports quarterly revenue of $543.9M, net income of $31.2M, free cash flow of $44.1M. Top institutional holders of EYE by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, WELLINGTON MANAGEMENT GROUP LLP, based on the most recent SEC filings. EYE trades on the Nasdaq exchange and files with the SEC under CIK 1710155. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EYE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for National Vision Holdings, Inc. directly from SEC EDGAR. National Vision Holdings, Inc.'s 13F Pro composite quality score has ranged between 35 and 67 since 2021, currently 55.4 — an improving long-term trajectory across 30 quarterly and live scoring snapshots.

✦

Fun facts about National Vision Holdings, Inc.

Quirks, history, and lore behind EYE — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · listed on Nasdaq · headquartered in Georgia · operates a large network of retail locations.
2
The Numbers
Runs roughly 1,100+ retail stores across the country and generates annual revenue in the low billions — not bad for a business built around a $49 exam.
3
The History
Founded in the 1990s, it grew by targeting value-conscious consumers who needed professional care but didn't want to pay luxury prices for it.
4
The Secret
It operates under multiple brand banners — including inside big-box and grocery retailers — making it one of the largest players in its niche without most people knowing one company owns them all.
5
The Lore
Its ticker symbol is a three-letter organ you use every waking second, and Wall Street analysts have definitely made the obvious pun in at least one research note.
6
The Giveaway
America's largest optical retail chain by store count, selling eyeglasses and contact lenses at affordable prices — because seeing clearly shouldn't cost an arm and a leg.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$543.9M

Net Income

Q1 2026

$31.2M

Free Cash Flow

Q1 2026

$44.1M

ROIC

Q1 2026

4.0%

D/E Ratio

Q1 2026

0.29

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+9.0% YoY

$1.99BFY 2025

FY20 $1.71BFY23 $1.76BFY24 $1.82BFY25 $1.99B

Net Income

+203.9% YoY

$29.6MFY 2025

FY20 $36.3MFY23 $-65.9MFY24 $-28.5MFY25 $29.6M

Operating Income

+667.9% YoY

$58.8MFY 2025

FY20 $87.0MFY23 $24.5MFY24 $-10.4MFY25 $58.8M

EPS (Diluted)

+202.8% YoY

$0.37FY 2025

FY20 $0.44FY23 $-0.84FY24 $-0.36FY25 $0.37

Total Assets

-1.2% YoY

$1.98BFY 2025

FY20 $2.33BFY23 $2.17BFY24 $2.01BFY25 $1.98B

Total Debt

-50.4% YoY

$266.3MFY 2025

FY20 $655.4MFY23 $468.8MFY24 $536.6MFY25 $266.3M

Op. Cash Flow

+9.5% YoY

$146.3MFY 2025

FY20 $235.0MFY23 $173.0MFY24 $133.6MFY25 $146.3M

Metric	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019	FY 2018
Revenue	$1.99B +9.0%	$1.82B +3.8%	$1.76B +2.6%	$1.71B -0.7%	$1.72B +12.2%	$1.54B
Net Income	$29.6M +203.9%	$-28.5M +56.8%	$-65.9M -281.7%	$36.3M +10.6%	$32.8M +38.7%	$23.7M
Operating Income	$58.8M +667.9%	$-10.4M -142.3%	$24.5M -71.9%	$87.0M +18.3%	$73.6M +73.7%	$42.4M
EPS (Diluted)	$0.37 +202.8%	$-0.36 +57.1%	$-0.84 -290.9%	$0.44 +10.0%	$0.40 +33.3%	$0.30
Total Assets	$1.98B -1.2%	$2.01B -7.6%	$2.17B -6.9%	$2.33B +14.8%	$2.03B +22.4%	$1.66B
Total Debt	$266.3M -50.4%	$536.6M +14.5%	$468.8M -28.5%	$655.4M +13.0%	$580.2M +0.4%	$578.1M
Operating Cash Flow	$146.3M +9.5%	$133.6M -22.8%	$173.0M -26.4%	$235.0M +42.3%	$165.1M +54.8%	$106.6M

AI Insight: EYE Financial Trends

EYE swung to $31M net income in Q2 2026 as revenue climbed 12% YoY and debt fell 75% since Q3 2024.

• Net income rebounded to $31M in Q2 2026 from $3M in Q1 2026; operating income reached $45M, highest in dataset.

• Total debt collapsed from $1,065M (Q2 2024) to $263M (Q2 2026), cutting net leverage dramatically.

• Revenue grew 12% YoY (Q2 2025: $486M → Q2 2026: $544M); operating cash flow accelerated to $62M.

⚠ Operating cash flow collapsed 78% from Q2 2026 ($62M) to Q1 2026 ($13M); seasonal or structural deterioration unclear.

⚠ Net income volatility remains high—swung from -$29M loss (Q4 2024) to profitability; margins still fragile.

AI Insight: EYE Ratio Trends

National Vision swung from Q4 2024 losses to Q2 2026 profitability, with operating margin rebounding to 8.3% and ROIC surging to 15.6%.

• Operating margin recovered from -5.9% in Q4 2024 to 8.3% in Q2 2026; net profit margin climbed to 5.7% from -6.5%.

• ROIC jumped to 15.6% in Q2 2026 versus -7.6% in Q4 2024; ROE improved to 13.9% from -14.0%.

• Leverage ratio (D/E) strengthened to 0.29 in Q2 2026 from 1.26 in Q2 2024, signaling deleveraging.

⚠ Q1 2026 showed margin compression to 1.3% OpMargin and 2.3% ROIC before Q2 2026 rebound; confirm sustainability.

⚠ Q3 2025 marked a trough with declining profitability metrics; Q2 2026 recovery needs sequential confirmation.

Get alerted when EYE's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for National Vision Holdings, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of EYE

BlackRock, Inc.
$298.8M11,535,638 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$148.8M5,746,983 sh
WELLINGTON MANAGEMENT GROUP LLP
$142.3M5,495,966 sh
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
$109.4M4,225,766 sh
DRIEHAUS CAPITAL MANAGEMENT LLC
$89.9M3,471,774 sh
VANGUARD CAPITAL MANAGEMENT LLC
$89.0M3,437,867 sh
AMERICAN CENTURY COMPANIES INC
$83.5M3,224,499 sh
STATE STREET CORP
$82.3M3,178,076 sh
DIMENSIONAL FUND ADVISORS LP
$79.3M3,062,191 sh
ALLIANCEBERNSTEIN L.P.
$64.5M2,497,080 sh

Fund	Value	Shares
BlackRock, Inc.	$298.8M	11,535,638
VANGUARD PORTFOLIO MANAGEMENT LLC	$148.8M	5,746,983
WELLINGTON MANAGEMENT GROUP LLP	$142.3M	5,495,966
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	$109.4M	4,225,766
DRIEHAUS CAPITAL MANAGEMENT LLC	$89.9M	3,471,774
VANGUARD CAPITAL MANAGEMENT LLC	$89.0M	3,437,867
AMERICAN CENTURY COMPANIES INC	$83.5M	3,224,499
STATE STREET CORP	$82.3M	3,178,076
DIMENSIONAL FUND ADVISORS LP	$79.3M	3,062,191
ALLIANCEBERNSTEIN L.P.	$64.5M	2,497,080

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put EYE on your watchlist

Track score changes the day National Vision Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is EYE a good stock to buy?

13F Pro's AI-powered analysis of National Vision Holdings, Inc. (EYE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EYE are available on the EYE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own EYE?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EYE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of National Vision Holdings, Inc.'s investment landscape.